Fig. 2.
Fig. 2. AC133, an early hematopoietic stem cell marker is expressed on VEGFR-2+ CEPs but not on mature endothelial cells. / CD34+ cells derived from mobilized peripheral blood (A) and HUVEC monolayers were analyzed for the expression of AC133. Only the circulating CD34+ VEGFR-2+ cells express AC133, but not mature adherent HUVECs (B, C). CD34+ cells coexpressing VEGFR-2 and AC133 were present in different hematopoietic sources (D), with the highest percentage found in cytokine-mobilized peripheral blood (2 ± 0.5%) and the lowest in unmobilized peripheral blood (0.4 ± 0.2%). X-axis represents log fluorescence intensity.

AC133, an early hematopoietic stem cell marker is expressed on VEGFR-2+ CEPs but not on mature endothelial cells.

CD34+ cells derived from mobilized peripheral blood (A) and HUVEC monolayers were analyzed for the expression of AC133. Only the circulating CD34+ VEGFR-2+ cells express AC133, but not mature adherent HUVECs (B, C). CD34+ cells coexpressing VEGFR-2 and AC133 were present in different hematopoietic sources (D), with the highest percentage found in cytokine-mobilized peripheral blood (2 ± 0.5%) and the lowest in unmobilized peripheral blood (0.4 ± 0.2%). X-axis represents log fluorescence intensity.

Close Modal

or Create an Account

Close Modal
Close Modal